Amgen Appoints Jonathan Peacock as CFO

Amgen, a manufacturer of human therapeutics, has appointed Jonathan Peacock as chief financial officer (CFO), effective 1 September 2010. He will be responsible for Amgen’s finance and investor relations operations. Peacock will report to Kevin Sharer, Amgen’s chairman and chief executive officer (CEO), and will succeed Michael Kelly, who served as acting CFO since May 2010.

Peacock joins from Novartis Pharmaceutical, where he served as CFO and administration officer since 2005. In that role, Peacock led the finance, information technology, purchasing, strategic planning and mergers and acquisitions functions.

Previously, Peacock was a partner at McKinsey and Company, where he was co-leader of the European corporate finance practice working in the consulting firm’s Amsterdam, Zurich and London offices. He also was a partner at Price Waterhouse in New York and London. He has an MA degree in Economics from the University of St Andrews in Scotland and is a chartered accountant (CA).


Related reading